1-stop shopping for COVID-19 resources from RSNA

Dave Pearson | | Health Imaging | Enterprise Imaging
COVID

The Radiological Society of North America has rounded up and gathered together its online COVID-19 resources, enabling easy engagement with all things imaging, coronavirus and RSNA.

Highlights include a COVID-19 imaging data repository, a free and open COVID-19 discussion community (registration required) and a COVID-19 case collection.

Also on offer are coronavirus-related webinars and targeted resources for radiology trainees.

For more of a one-stop shopping experience, RSNA has aggregated most of these links—and others—here.

Dave Pearson
Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Related Content

Chinese hackers use malware disguised as imaging viewers to steal patient data
Newly launched report feature provides patients with a visual aid to their imaging
Sectra and Siemens Healthineers partner to improve CT workflows
GE HealthCare taps Enlitic for large-scale imaging data migration plans
Top performing PACS companies based on user feedback
Enterprise imaging expands in smaller and midsized hospitals

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.